Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial

Autor: Chi, Kim N, Protheroe, Andrew, Rodríguez-Antolín, Alfredo, Facchini, Gaetano, Suttman, Henrik, Matsubara, Nobuaki, Ye, Zhangqun, Keam, Bhumsuk, Damião, Ronaldo, Li, Tracy, McQuarrie, Kelly, Jia, Bin, De Porre, Peter, Martin, Jason, Todd, Mary B, Fizazi, Karim
Zdroj: In The Lancet Oncology February 2018 19(2):194-206
Databáze: ScienceDirect